Skip to main content
Improve Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,954 across all filing types
Latest filing 2021-06-15 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
公司章程
Governance Information Classification · 100% confidence The document is titled "公司章程" which translates to "Articles of Association" or "Company Bylaws." It contains detailed provisions about the company's organizational structure, shareholder rights, board responsibilities, meeting procedures, share issuance, and other governance-related rules. There is no indication of financial data, audit results, earnings, or any report publication. Instead, it is a governance document outlining internal rules and regulations of the company. Therefore, this document fits the category of Governance Information (CGR). The document length is substantial and contains detailed governance content, confirming it is not a mere announcement or a short notice.
2021-06-15 Chinese
关于公司监事辞职及补选第五届监事会非职工代表监事的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of a company supervisor and the nomination of a new supervisor candidate. It includes details about the resignation, the legal compliance related to the resignation, and the nomination process for the replacement supervisor. There are no financial statements, earnings data, or detailed management discussion. The content focuses on changes in the company's supervisory board members, which fits the category of Board/Management Information (MANG). The document length is short and it is not a report or a presentation but an official announcement of management changes.
2021-06-15 Chinese
关于授权董事会办理公司产品、业务所涉资质、认证等变更、申办手续的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding authorization for the board to handle changes and applications related to product and business qualifications and certifications due to a change in the company's registered address. It includes details about the board meeting resolutions and the impact on company operations. The document is short (914 characters) and does not contain financial statements or detailed financial data. It is not an annual report, interim report, earnings release, or any detailed financial or governance report. It is an official regulatory announcement about administrative and operational changes requiring shareholder approval and regulatory review. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-06-15 Chinese
关于与珠海横琴新区（横琴自贸试验区）管理委员会签署战略合作协议的公告
Regulatory Filings Classification · 95% confidence The document is an announcement by Guangzhou Yangpu Medical Technology Co., Ltd. regarding the signing of a strategic cooperation agreement with the Zhuhai Hengqin New Area Management Committee. It details the framework and intentions of the cooperation, the approval process including board and shareholder meetings, and the potential impacts and risks. There are no financial statements or detailed financial data presented. The document is a formal announcement of a strategic cooperation agreement rather than a full report or financial filing. It is not a report publication announcement since it contains substantive content about the agreement itself. The document fits best into the category of a Regulatory Filing (RNS) as it is a general regulatory announcement about a strategic cooperation agreement and related corporate governance matters without financial results or detailed financial disclosures.
2021-06-15 Chinese
第五届董事会第九次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the ninth meeting of the fifth board of directors of Guangzhou Yangpu Medical Technology Co., Ltd. It details various board decisions such as signing strategic cooperation agreements, changing company registration details, authorizing handling of certifications, capital increase in a subsidiary, termination of a PPP cooperation project, and scheduling a shareholders' meeting to approve these matters. The document includes voting results and references to further announcements on the official disclosure website. It is not a full report like an annual or interim report, nor is it a call transcript or earnings release. It is a board meeting resolution announcement, which fits the category of Board/Management Information (MANG). The document length is 2675 characters, which is typical for such announcements. Therefore, the classification is MANG with high confidence.
2021-06-15 Chinese
广州阳普医疗科技股份有限公司2017年面向合格投资者公开发行创新创业公司债券（第一期）2021年跟踪评级报告
Audit Report / Information Classification · 95% confidence The document is titled as a "2021 Tracking Rating Report" for a bond issued by Guangzhou Yangpu Medical Technology Co., Ltd. It contains detailed credit rating information, financial data, business overview, operational environment, and risk factors related to the company and its bond issuance. The content includes extensive financial metrics, credit rating opinions, bond details, and company operational analysis. It is a comprehensive credit rating report rather than a general annual report or earnings release. It is not a regulatory announcement or a brief notice but a full report with substantive financial and operational data. Therefore, it fits best into the category of an Audit Report / Information (AR), as it is a standalone credit rating report related to the bond and company creditworthiness, including financial analysis and risk assessment, but not a full annual report or earnings release. Q1 2021
2021-06-15 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.